Advocate-General Kokott of the ECJ has delivered an important opinion on the application of the presumption of decisive influence in the context of a jurisdictional analysis under the recast Brussels I Regulation.
The Dutch collective redress system continues to be dynamic, with interesting decisions being provided by the courts. In this class action update, Noor Hogerzeil and Damiën Berkhout provide comments on two recent cases. In the first case, the Dutch Supreme Court provides an important decision on the applicable limitation period for individuals after a successful collective action. In the second case, the court provides more clarity on the admissibility requirements in case of general interest and ESG claims.
Lindenbaum is moving to its new Amsterdam offices at Concertgebouwplein 13. We look forward to meeting you there.
Lindenbaum's managing partner Damiën Berkhout provided legal and governance advice to the management board of Beequip in the context of the transaction between NIBC and Apollo.
The Amsterdam District Court ruled that the representative organization Stichting Farma Ter Verantwoording is admissible in its collective action against pharmaceutical giant AbbVie. The case now moves on to the merits phase, in which the court will assess whether Abbvie abused its dominant position and violated human rights by charging excessive prices for its Humira medicine.
Lindenbaum B.V.
Concertgebouwplein 13-H
1071 LL, Amsterdam
